{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:46:38Z","timestamp":1792424798135,"version":"4.5.0"},"reference-count":41,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K01 HL148402"],"award-info":[{"award-number":["K01 HL148402"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Study Objective<\/jats:title><jats:p>The immunosuppressant tacrolimus is a first\u2010line agent to prevent graft rejection following pediatric heart transplant; however, it suffers from extensive inter\u2010patient variability and a narrow therapeutic window. Personalized tacrolimus dosing may improve transplant outcomes by more efficiently achieving and maintaining therapeutic tacrolimus concentrations. We sought to externally validate a previously published population pharmacokinetic (PK) model that was constructed with data from a single site.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Source<\/jats:title><jats:p>Data were collected from Seattle, Texas, and Boston Children's Hospitals, and assessed using standard population PK modeling techniques in NONMEMv7.2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Results<\/jats:title><jats:p>While the model was not successfully validated for use with external data, further covariate searching identified weight (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001 on both volume and elimination rate) as a model\u2010significant covariate. This refined model acceptably predicted future tacrolimus concentrations when guided by as few as three concentrations (median prediction error\u2009=\u20097%; median absolute prediction error\u2009=\u200927%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings support the potential clinical utility of a population PK model to provide personalized tacrolimus dosing guidance.<\/jats:p><\/jats:sec>","DOI":"10.1002\/phar.2836","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T21:19:56Z","timestamp":1686950396000},"page":"650-658","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant"],"prefix":"10.1002","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-7902","authenticated-orcid":false,"given":"Joseph E.","family":"Rower","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology University of Utah College of Pharmacy  Salt Lake City Utah USA"},{"name":"Center for Human Toxicology University of Utah College of Pharmacy  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-2991","authenticated-orcid":false,"given":"Autumn","family":"McKnite","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology University of Utah College of Pharmacy  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5294-6821","authenticated-orcid":false,"given":"Borah","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology University of Washington and Seattle Children's Hospital  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-1532","authenticated-orcid":false,"given":"Kevin P.","family":"Daly","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology Harvard Medical School\/Boston Children's Hospital  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8333-5142","authenticated-orcid":false,"given":"Kyle D.","family":"Hope","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lillie Frank Abercrombie Division of Pediatric Cardiology, Texas Children's Hospital Baylor College of Medicine  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2739-4364","authenticated-orcid":false,"given":"Antonio G.","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lillie Frank Abercrombie Division of Pediatric Cardiology, Texas Children's Hospital Baylor College of Medicine  Houston Texas USA"},{"name":"Division of Pediatric Cardiology University of Utah\/Intermountain Primary Children's Hospital  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-7960","authenticated-orcid":false,"given":"Kimberly M.","family":"Molina","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology University of Utah\/Intermountain Primary Children's Hospital  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2016.08.018"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2016.09.001"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.05.111"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12174"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181a8f02a"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0396-1"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.75"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1501-0"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12649"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12276"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.9.1905"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31823415cc"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.210"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1330-6"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529060-00003"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2017-000147"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02170.x"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241110-00003"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9120(91)80019-Y"},{"issue":"5","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0090-9556(25)07572-5","article-title":"FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4","volume":"22","author":"Karanam B","year":"1994","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0090-9556(25)08793-8","article-title":"Cytochrome P\u2010450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat","volume":"20","author":"Sattler M","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2563"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328351d47f"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.08.001"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12790"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00942-y"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109164"},{"key":"e_1_2_10_29_1","first-page":"49","article-title":"Hematocrit levels in children at sea level and at high altitude: effect of adrenal androgens","volume":"65","author":"G\u00f3\u00f1ez C","year":"1993","journal-title":"Hum Biol"},{"issue":"5","key":"e_1_2_10_30_1","first-page":"811","article-title":"Altitude adaptation through hematocrit changes","volume":"58","author":"Zubieta\u2010Calleja G","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2006.049734"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1994.tb03752.x"},{"issue":"4","key":"e_1_2_10_33_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0090-9556(25)07474-4","article-title":"Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance","volume":"21","author":"Piekoszewski W","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200210000-00005"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00581-1"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13059"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2601"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001002"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200304000-00004"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105237"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2521-6"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12830"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:26:24Z","timestamp":1761045984000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1002\/phar.2836"],"URL":"https:\/\/doi.org\/10.1002\/phar.2836","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"2022-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}